How Asia‑Based Companies Should Respond as U.S. Enforcement Is Unpaused and APAC Regulation Hits Fast‑Forward

Despite ongoing risks of FCPA enforcement, for Asia-based companies, a more immediate and consequential development is the growth in activity by Asian regulators. Contrary to U.S. developments in 2025 and 2026 – marked by the pause and refocusing of FCPA enforcement efforts – anti-corruption enforcement has expanded in several key Asia-Pacific jurisdictions. In this guest article, Hogan Lovells partners Khushaal Ved and Matthew Sullivan, with associate Han Liang Lie, examine how Asia‑based companies should be reassessing their anti-corruption compliance efforts, given the evolving enforcement priorities of U.S. and Asian regulators. For more from Hogan Lovells, see “A Prescription for Corruption Risks in the Asian Healthcare Sector” (Jun. 18, 2025).

To read the full article

Continue reading your article with an ACR subscription.